NL8601977A - Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking. - Google Patents
Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking. Download PDFInfo
- Publication number
- NL8601977A NL8601977A NL8601977A NL8601977A NL8601977A NL 8601977 A NL8601977 A NL 8601977A NL 8601977 A NL8601977 A NL 8601977A NL 8601977 A NL8601977 A NL 8601977A NL 8601977 A NL8601977 A NL 8601977A
- Authority
- NL
- Netherlands
- Prior art keywords
- pharmaceutical preparations
- coenzyme
- preparations according
- alkaloids
- flunarizine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH334485 | 1985-08-02 | ||
| CH3344/85A CH670763A5 (it) | 1985-08-02 | 1985-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8601977A true NL8601977A (nl) | 1987-03-02 |
Family
ID=4253937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8601977A NL8601977A (nl) | 1985-08-02 | 1986-08-01 | Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4778798A (it) |
| JP (1) | JPS6253932A (it) |
| BE (2) | BE905198A (it) |
| CH (1) | CH670763A5 (it) |
| DE (1) | DE3625877A1 (it) |
| FR (1) | FR2591481B1 (it) |
| GB (1) | GB2178314B (it) |
| IT (1) | IT1197061B (it) |
| NL (1) | NL8601977A (it) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH662505A5 (it) * | 1985-04-30 | 1987-10-15 | Seuref Ag | Composizioni farmaceutiche ad azione protettiva vascolare. |
| US4871731A (en) * | 1987-10-07 | 1989-10-03 | Marion Laboratories, Inc. | Captopril and diltiazem composition and the like |
| JPH02188523A (ja) * | 1989-01-13 | 1990-07-24 | M S C:Kk | 睡眠時無呼吸症治療薬 |
| DE3918082A1 (de) * | 1989-06-02 | 1991-01-24 | Max Planck Gesellschaft | Mittel gegen autoimmunerkrankungen |
| FR2655854A1 (fr) * | 1989-12-19 | 1991-06-21 | Poissonnet Claude | Medication nouvelle pour le traitement de surcharges lipidiques. |
| US5145859A (en) * | 1991-03-20 | 1992-09-08 | Case Western Reserve University | Methods of treating interstitial cystitis and urethral syndrome |
| US6461593B1 (en) * | 1992-02-19 | 2002-10-08 | Biomedical And Clinical Research | Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease |
| IT1265312B1 (it) * | 1993-12-21 | 1996-10-31 | Indena Spa | Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di |
| US20020032160A1 (en) * | 1995-02-24 | 2002-03-14 | Nyce Jonathan W. | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
| US5660835A (en) * | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
| CA2272971C (en) * | 1998-10-29 | 2008-01-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Quinone derivatives for treating or preventing diseases associated with iron overload |
| DE19928528C2 (de) * | 1999-06-22 | 2002-10-17 | Heinz Kiefer | Arzneimittel (Antiarteriosklerotikum) zur Vorbeugung und Linderung von Beschwerden bei arteriellen Durchblutungsstörungen auf der Grundlage von Ginkgobiloba |
| GB2368012A (en) * | 2000-10-19 | 2002-04-24 | Nicholas John Larkins | Preparation for the relief of inflammatory disease |
| GB0209254D0 (en) * | 2002-04-23 | 2002-06-05 | Larkins Nicholas J | Preparation for the relief of disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5938203B2 (ja) * | 1976-04-26 | 1984-09-14 | エーザイ株式会社 | 補酵素ｑを主成分とする脳循環障害治療剤 |
| JPS5913710A (ja) * | 1982-07-15 | 1984-01-24 | Shiseido Co Ltd | 養毛料 |
| CH655005A5 (it) * | 1983-02-16 | 1986-03-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare. |
-
1985
- 1985-08-02 CH CH3344/85A patent/CH670763A5/it not_active IP Right Cessation
-
1986
- 1986-07-25 GB GB8618249A patent/GB2178314B/en not_active Expired - Fee Related
- 1986-07-30 BE BE2/61022A patent/BE905198A/nl not_active IP Right Cessation
- 1986-07-31 US US06/892,247 patent/US4778798A/en not_active Expired - Fee Related
- 1986-07-31 DE DE19863625877 patent/DE3625877A1/de active Granted
- 1986-08-01 IT IT21393/86A patent/IT1197061B/it active
- 1986-08-01 FR FR868611182A patent/FR2591481B1/fr not_active Expired - Fee Related
- 1986-08-01 JP JP61182591A patent/JPS6253932A/ja active Pending
- 1986-08-01 NL NL8601977A patent/NL8601977A/nl not_active Application Discontinuation
- 1986-08-04 BE BE2/61026A patent/BE905211A/nl not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2591481A1 (fr) | 1987-06-19 |
| GB8618249D0 (en) | 1986-09-03 |
| IT8621393A0 (it) | 1986-08-01 |
| IT1197061B (it) | 1988-11-25 |
| US4778798A (en) | 1988-10-18 |
| DE3625877C2 (it) | 1992-04-02 |
| JPS6253932A (ja) | 1987-03-09 |
| GB2178314B (en) | 1990-02-21 |
| BE905211A (nl) | 1987-02-04 |
| FR2591481B1 (fr) | 1992-05-29 |
| DE3625877A1 (de) | 1987-02-05 |
| BE905198A (nl) | 1986-11-17 |
| CH670763A5 (it) | 1989-07-14 |
| GB2178314A (en) | 1987-02-11 |
| IT8621393A1 (it) | 1988-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL8601977A (nl) | Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking. | |
| US5283257A (en) | Method of treating hyperproliferative vascular disease | |
| JPH069390A (ja) | 血管過剰増殖病治療用組成物 | |
| JPH0649651B2 (ja) | 心筋虚血治療用医薬組成物 | |
| KR20010013690A (ko) | 동맥 혈전증의 치료와 예방을 위한 조성물과 그 조성물단독 및/또는 혈소판 응집방지제와 결합한 인자 Ｘａ억제제의 사용법 | |
| US4886820A (en) | Dihydropyridine combination product comprising a dihydropyridine compound and a cardioactive nitrate | |
| CA1036937A (en) | Pharmaceutical heparinoidic factor-containing composition and therapeutic use thereof | |
| EP0612733A1 (en) | Use of Phthaloylhydrazide Derivatives as Anti-Hypoxic and defensive Agents | |
| WO1992003130A1 (en) | Use of aryl hydroxyurea compounds for the treatment of atherosclerosis | |
| US5366960A (en) | Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol | |
| US4298611A (en) | Process for reducing blood pressure in animals | |
| US4436732A (en) | Medicated compound for treating diseases infected by virus of the herpes group | |
| EP0444546B1 (en) | Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents | |
| US6455553B1 (en) | Method for treating a demyelinating condition | |
| KR100508623B1 (ko) | 마크롤라이드 화합물의 신규한 용도 | |
| KR100194825B1 (ko) | 말초 순환 개선제 | |
| EP0310259B1 (en) | Eperisone as a hypotensive agent | |
| CA1172566A (en) | Method for producing pharmaceutical preparation | |
| JPS6379831A (ja) | １，４−ジビドロピリジン誘導体およびアシル化１，２，３，４−テトラヒドロイソキノリン−３−カルボン酸を含有する医薬組成物 | |
| CA1285880C (en) | Use of terguride as a geriatric agent | |
| EP0115331B1 (en) | Medicament for cerebral apoplexy | |
| KR960014874B1 (ko) | 요산 배출용 조성물 | |
| JPH02111722A (ja) | 虚血性臓器障害予防・治療剤 | |
| US4847280A (en) | Novel treatment | |
| US5461072A (en) | Use of aryl hydroxyurea compounds for the treatment of atherosclerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed |